By contrast, the majority of Fgfr2ΔE18 glands contained FGFR2-positive high-grade adenocarcinomas or E-cadherin-negative invasive lobular carcinomas or sarcomatoid tumours (Extended Data Fig. 8). This evidence concerns the gene CDH1 and invasive lobular breast carcinoma.